Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study

Thromb Res. 2022 Apr:212:19-21. doi: 10.1016/j.thromres.2022.02.001. Epub 2022 Feb 12.

Authors

Étienne Beaudoin¹, Shaima Kaka², Elisabeth Gagnon¹, Andréanne Durivage¹, Isabelle Boulais¹, Geneviève Le Templier¹, Dominique Toupin¹, Grégoire Le Gal², Bobby Gouin³

Affiliations

¹ Département de Médecine, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Canada.
² Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
³ Département de Médecine, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Canada. Electronic address: bobby.gouin@usherbrooke.ca.

PMID: 35217330
DOI: 10.1016/j.thromres.2022.02.001

No abstract available

Keywords: Anticoagulants; D-dimer; Direct oral; Pulmonary embolism; Recurrence; Venous thromboembolism.

Publication types

Letter
Multicenter Study

MeSH terms

Anticoagulants / therapeutic use
Fibrin Fibrinogen Degradation Products
Humans
Pulmonary Embolism* / diagnosis
Pulmonary Embolism* / drug therapy
Retrospective Studies
Venous Thromboembolism*

Substances

Anticoagulants
Fibrin Fibrinogen Degradation Products
fibrin fragment D